Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Genesis 2 Church
WARNING LETTER
•Genesis 2 Church•March 31, 2020

FDA WARNING_LETTER - Genesis 2 Church - March 31, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA and FTC issued a Warning Letter on April 8, 2020, to Genesis II Church of Health and Healing after reviewing their websites (e.g., genesis2church.ch, newg2sacraments.org) between March 27-31, 2020. The agencies found the firm was selling Miracle Mineral Solution (MMS), also known as chlorine dioxide, with unproven claims to cure, mitigate, treat, or prevent Coronavirus Disease 2019 (COVID-19) during a declared public health emergency. The letter identifies MMS as an unapproved new drug under 21 U.S.C. § 355(a) and a misbranded drug under 21 U.S.C. § 352(f)(1). Its introduction into interstate commerce is prohibited under 21 U.S.C. §§ 331(a) and (d), and misbranding while held for sale is prohibited under 21 U.S.C. § 331(k). Additionally, the FTC found the firm's COVID-19 treatment claims to be unsubstantiated by competent and reliable scientific evidence, violating the FTC Act, 15 U.S.C. § 41 et seq. The FDA has previously warned consumers about MMS's dangerous side effects. The firm must immediately cease selling these unapproved products and review all promotional materials. Within 48 hours, they must email both FDA and FTC, detailing corrective actions taken, steps to prevent recurrence, and supporting documentation. Failure to comply may lead to legal action, including seizure, injunctions, being added to FDA's public fraud list, and potential consumer restitution for FTC violations. Products are also subject to import detention.

Company
Genesis 2 Church
Inspection Date
March 31, 2020
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Donald D. Ashley (Director)
  • Richard A. Quaresima
Open in Dashboard

ID · 3e19eb98-9e5e-427c-9312-af50a5e1a6c7

Violation Codes5
21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 331(d)21 U.S.C. 331(k)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.